indicated for the maintenance treatment of schizophrenia in adult patients stabilized with oral aripiprazole.
ABILIFY is indicated for the treatment of schizophrenia in adults and adolescents aged 15 years and over.
ABILIFY is indicated for the treatment of moderate to severe manic episodes in type I bipolar disorder and for the prevention of new manic episodes in adults who have experienced predominantly manic episodes and whose manic episodes have responded to treatment with aripiprazole.
ABILIFY is indicated for the treatment of moderate to severe manic episodes of bipolar I disorder in adolescents 13 years of age and older for up to 12 weeks.
WHERE TO BUY Abilify